Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$21,662,139
in 5 filings, $21.7M under 10b5-1 plans

Net −$21,662,139. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-28 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Sale 10b5-1 −10,000 $52.04 $520K 15,480
2024-06-28 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −10,000 5,000
2024-06-27 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +10,000 $22.50 $225K 25,480
2024-06-27 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Sale 10b5-1 −10,000 $51.93 $519K 15,480
2024-06-27 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −10,000 15,000
2024-06-26 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Exercise or conversion 10b5-1 +10,000 $22.50 $225K 25,480
2024-06-26 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Sale 10b5-1 −10,000 $51.82 $518K 15,480
2024-06-26 LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −10,000 25,000
2024-06-18 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion 10b5-1 +10,000 $8.11 $81K 178,176
2024-06-18 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale 10b5-1 −10,000 $49.43 $494K 168,176
2024-06-18 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −10,000 11,715
2024-06-12 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Grant or award · Restricted Stock Units +20,137 20,137
2024-06-12 Posard Matthew L. Director Sale −10,000 $50.62 $506K 99,755
2024-06-11 Posard Matthew L. Director Sale −10,000 $50.01 $500K 109,755
2024-05-22 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion 10b5-1 +10,000 $8.11 $81K 178,176
2024-05-22 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale 10b5-1 −10,000 $45.38 $454K 168,176
2024-05-22 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −10,000 21,715
2024-05-21 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion 10b5-1 +10,000 $8.11 $81K 178,176
2024-05-21 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Sale 10b5-1 −10,000 $45.16 $452K 168,176
2024-05-21 LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER Exercise or conversion · Option to Purchase Common Stock 10b5-1 −10,000 31,715

Page 29 of 48 · 944 trades